Amazon cover image
Image from Amazon.com

Cardiovascular pharmacotherapeutics / edited by William H. Frishman, Edmund H. Sonnenblick, Domenic A. Sica.

Contributor(s): Publication details: New York : McGraw-Hill, Medical Pub. Division, c2003.Edition: 2nd editionDescription: xxiv, 1072 p. : ill. ; 29 cmISBN:
  • 0071369813
Subject(s): DDC classification:
  • QV 150 C2678 2003
Online resources:
Contents:
Part 1 Introductory Chapters 1. Basic Principles 2. Placebo Effect 3. Compliance 4. New Drug Development 5. Pharmacoeconomics 6. Cardiovascular Pharm History Part 2 Drug Classes 7. Alpha & Beta blockers 8. Cholinergic & Anticholinergic Drugs 9. Calcium blockers 10. RAS – ACE, ARBs 11. Diuretic 12. Mag, K+, Calcium 13. Digitalis and Inotropic Agents 14. Organic Nitrates and nitroprusside 15. Central Action, Ganglionic blockers, neuron depletors 16. Nonspecific antihypertensive vasodilators 17. Antiarrhythmics 18. Antiplatelets & Antithrombotics 19. Thrombolytics 20. Lipid lowering/effects of CV drugs on lipoproteins 21. Combination 22. Smoking, nicotine 23. Fish oils 24. Antioxidant vitamins and free radical scavengers 25. Prostacyclin 26. Dopamine Part 3 New Drugs Classes in Development 27. Natriuretic peptides and neutral endopeptidase 28. Potassium channel and sodium-hydrogen channel 29. Serotonin 30. Imidazoline 31. Endothelin 32. Adenosine 33. Nitric oxide 34. Renin 35. Vasopressin 36. Hormones 37. Innovative approaches for myocardial ischemia – focus on angiogenesis 38. Angiogenesis 39. Innovative drug targets 40. Restenosis 41. Gene therapy 42. Apoptosis 43. Matrix Metalloproteinase 44. NSAIDS & Cox 2 inhibitors 45. Prostaglandins & P450 Metabolites 46. Innovative med. approaches to hyperlipidemia
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Book Open Access Book Open Access Health Sciences Library QV 150 C2678 2003 (Browse shelf(Opens below)) 1 Available MBAL22020911

Includes bibliographical references and index.

Part 1 Introductory Chapters
1. Basic Principles
2. Placebo Effect
3. Compliance
4. New Drug Development
5. Pharmacoeconomics
6. Cardiovascular Pharm History

Part 2 Drug Classes
7. Alpha & Beta blockers
8. Cholinergic & Anticholinergic Drugs
9. Calcium blockers
10. RAS – ACE, ARBs
11. Diuretic
12. Mag, K+, Calcium
13. Digitalis and Inotropic Agents
14. Organic Nitrates and nitroprusside
15. Central Action, Ganglionic blockers, neuron depletors
16. Nonspecific antihypertensive vasodilators
17. Antiarrhythmics
18. Antiplatelets & Antithrombotics
19. Thrombolytics
20. Lipid lowering/effects of CV drugs on lipoproteins
21. Combination
22. Smoking, nicotine
23. Fish oils
24. Antioxidant vitamins and free radical scavengers
25. Prostacyclin
26. Dopamine

Part 3 New Drugs Classes in Development
27. Natriuretic peptides and neutral endopeptidase
28. Potassium channel and sodium-hydrogen channel
29. Serotonin
30. Imidazoline
31. Endothelin
32. Adenosine
33. Nitric oxide
34. Renin
35. Vasopressin
36. Hormones
37. Innovative approaches for myocardial ischemia – focus on angiogenesis
38. Angiogenesis
39. Innovative drug targets
40. Restenosis
41. Gene therapy
42. Apoptosis
43. Matrix Metalloproteinase
44. NSAIDS & Cox 2 inhibitors
45. Prostaglandins & P450 Metabolites
46. Innovative med. approaches to hyperlipidemia

There are no comments on this title.

to post a comment.